Friday, July 11, 2025
  • Login
Euro Times
No Result
View All Result
  • Home
  • Finance
  • Business
  • World
  • Politics
  • Markets
  • Stock Market
  • Cryptocurrency
  • Investing
  • Health
  • Technology
  • Home
  • Finance
  • Business
  • World
  • Politics
  • Markets
  • Stock Market
  • Cryptocurrency
  • Investing
  • Health
  • Technology
Euro Times
No Result
View All Result

Pfizer CEO tests positive for COVID for a second time By Reuters

by Reuters
September 24, 2022
in Stock Market
Reading Time: 2 mins read
A A
0
Home Stock Market
Share on FacebookShare on Twitter


© Reuters. FILE PHOTO: Albert Bourla, CEO of Pfizer attends a discussion at the World Economic Forum (WEF) in Davos, Switzerland May 25, 2022. REUTERS/Arnd Wiegmann

(Reuters) -Pfizer Inc Chief Executive Officer Albert Bourla said on Saturday he had tested positive for COVID-19.

“I’m feeling well and symptom free,” Bourla said in a statement.

Bourla, 60, back in August had contacted COVID and had started a course of the company’s oral COVID-19 antiviral treatment, Paxlovid.

Paxlovid is an antiviral medication that is used to treat high-risk people, such as older patients.

Bourla has received four doses of the COVID vaccine developed by Pfizer (NYSE:) and its German partner BioNTech.

The chief executive said he has not yet taken the new bivalent booster.

Developed by Moderna (NASDAQ:) and the team of Pfizer and BioNTech, the new so-called bivalent shots aim to tackle the BA.5 and BA.4 Omicron subvariants, which make up 84.8% and 1.8%, respectively, of all circulating variants in the United States, based on latest data.

“I’ve not had the new bivalent booster yet, as I was following CDC guidelines to wait three months since my previous COVID case which was back in mid-August,” Bourla added.

In August, the FDA authorized Pfizer and Moderna’s updated booster shots that target the dominant BA.4 and BA.5 Omicron subvariants.

A federal health agency said this week that over 25 million doses of the so-called bivalent shots had been sent out. That consisted of mostly the Pfizer/BioNTech vaccine, as production of the Moderna vaccine ramps up.



Source link

Tags: CEOCovidPfizerPositiveReutersteststime
Previous Post

Behind the new anxiety screening recommendation : NPR

Next Post

Biden’s anemic crypto framework offered us nothing new

Related Posts

Nu Holdings: The Fintech Stock With Strong Long-Term Growth Potential (NYSE:NU)

Nu Holdings: The Fintech Stock With Strong Long-Term Growth Potential (NYSE:NU)

by Analysis Fundamental
July 9, 2025
0

This text was written byComply withI'm an skilled Threat Administration Enterprise Analyst at a Systemic Greek Financial institution, with a...

Antofagasta: Robust Prospects For Long-Term Dividend Investors (ANFGF)

Antofagasta: Robust Prospects For Long-Term Dividend Investors (ANFGF)

by Alberto Abaterusso
July 9, 2025
0

This text was written byObserveAlberto holds a Grasp's diploma in Enterprise Economics. Throughout his educational profession he acquired an in...

Oklo: The Most Exciting Zero-Revenue Stock (NYSE:OKLO)

Oklo: The Most Exciting Zero-Revenue Stock (NYSE:OKLO)

by Michael Wiggins De Oliveira
July 8, 2025
0

This text was written byObserveMichael Wiggins De Oliveira is an inflection investor. This implies shopping for into low cost corporations...

B-Stock’s Summer Teammate Spotlight 2025: Meet Mia Paulding

B-Stock’s Summer Teammate Spotlight 2025: Meet Mia Paulding

by Andrea Vargas
July 8, 2025
0

B-Inventory is so excited to welcome Mia Paulding to the Purchaser Account Administration staff this summer time! As a summer...

B-Stock’s Summer Teammate Spotlight 2025: Meet Alyssa Shum

B-Stock’s Summer Teammate Spotlight 2025: Meet Alyssa Shum

by Andrea Vargas
July 8, 2025
0

B-Inventory is so excited to welcome Alyssa Shum to the Product Design group this summer time! As a summer time...

Dell Stock Is Fairly Valued With CSG Struggles (NYSE:DELL)

Dell Stock Is Fairly Valued With CSG Struggles (NYSE:DELL)

by Jia Ming Eow
July 7, 2025
0

This text was written byObserve19 12 months previous passionate dealer managing a 6 determine portfolio attempting to and beating the...

Next Post
Biden’s anemic crypto framework offered us nothing new

Biden's anemic crypto framework offered us nothing new

Do This ASAP – Investment Watch

Do This ASAP – Investment Watch

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Dividend Kings In Focus: ABM Industries

Dividend Kings In Focus: ABM Industries

July 11, 2025
8th CPC Revised Pension Estimates: Are you Level 2, 4, 6, 8 and 10 employee? Know your projected revised pension at 2.08 and 2.57 fitment factors

8th CPC Revised Pension Estimates: Are you Level 2, 4, 6, 8 and 10 employee? Know your projected revised pension at 2.08 and 2.57 fitment factors

July 11, 2025
Russian basketball player arrested on suspicion of carrying out ransomware attacks

Russian basketball player arrested on suspicion of carrying out ransomware attacks

July 11, 2025
Trump announces 35% tariffs on Canada starting Aug. 1, warns of higher levies

Trump announces 35% tariffs on Canada starting Aug. 1, warns of higher levies

July 11, 2025
Why ACA health insurance premiums may see ‘sharp’ increase in 2026

Why ACA health insurance premiums may see ‘sharp’ increase in 2026

July 11, 2025
Robinhood Offers Crypto Trading “at the Lowest Cost,” but Is It False Advertising?

Robinhood Offers Crypto Trading “at the Lowest Cost,” but Is It False Advertising?

July 11, 2025
Euro Times

Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.

CATEGORIES

  • Business
  • Cryptocurrency
  • Finance
  • Health
  • Investing
  • Markets
  • Politics
  • Stock Market
  • Technology
  • Uncategorized
  • World

LATEST UPDATES

Dividend Kings In Focus: ABM Industries

8th CPC Revised Pension Estimates: Are you Level 2, 4, 6, 8 and 10 employee? Know your projected revised pension at 2.08 and 2.57 fitment factors

  • Disclaimer
  • Privacy Policy
  • DMCA
  • Cookie Privacy Policy
  • Terms and Conditions
  • Contact us

Copyright © 2022 - Euro Times.
Euro Times is not responsible for the content of external sites.

No Result
View All Result
  • Home
  • Finance
  • Business
  • World
  • Politics
  • Markets
  • Stock Market
  • Cryptocurrency
  • Investing
  • Health
  • Technology

Copyright © 2022 - Euro Times.
Euro Times is not responsible for the content of external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In